Identifying medications underlying communication atypicalities in psychotic and affective disorders: A pharmacovigilance study within the FDA Adverse Event Reporting System
- Michele Fusaroli
- , Arndis Simonsen
- , Stephanie A. Borrie
- , Daniel M. Low
- , Alberto Parola
- , Emanuel Raschi
- , Elisabetta Poluzzi
- , Riccardo Fusaroli
No endorsements
This article has not been endorsed yet.
Like this work?
Let others know. Sign in to add your endorsement.